NeVa CLEAR study results & significance

Primary results from the prospective, international, multicenter, FDA IDE study CLEAR, demonstrate highly compelling clinical outcomes with Vesalio’s NeVa™ thrombectomy device in treating large vessel occlusion acute ischemic stroke.

Watch Prof. Laurent Spelle (Paris, FRANCE), Prof. Raul Nogueira (Pittsburgh, U.S.), and Prof. Serdar Geyik (Istanbul, TURKEY) discuss the findings:

- The design of the CLEAR Study

- Procedural success, safety, and outcomes with NeVa

- Key points to remember and considerations for clinical practice.

To access the CLEAR publication, click here: https://jnis.bmj.com/content/early/2023/12/02/jnis-2023-020960  

NeVa is CE-approved. NeVa is not cleared in the U.S.